Medicare Price Negotiation Savings Would Rise To $101Bn With Revisions To Legislation – CBO

Latest version of Medicare price negotiation and price inflation rebate provisions are expected to lower federal government costs by about $200bn over 10 years.

CBO Continues TO Estimate 10 Fewer Drugs Would Be Introduced In US Over Next Three Decades Because Of The Legislation • Source: Shutterstock

The US Congressional Budget Office projects that revisions to the Medicare price negotiation provisions in the drug pricing reform legislation released recently by the Senate Finance Committee will produce nearly $23bn more savings to the federal government than the version approved by the House last fall. Savings from negotiation are now expected to reach $101.8bn, according to the score released by CBO 8 June.

The higher projections could be due to a more explicit requirement in the Senate bill that a certain number of...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access